JSRM Launches "REAP" Service, a Regenerative Medicine Data Registration System for Unrestricted Clinical Practice
The Japanese Society for Regenerative Medicine (JSRM) is pleased to announce the launch of the “REAP (Regenerative medicine Evidence Accumulation Platform)” service, a new platform for registering medical data and advanced medical data in the Regenerative Medicine Data Accumulation System. The service will be available for free medical services and advanced medical services. This service will be a registry service for unrestricted medical care that can be operated on the same platform as the regenerative medicine data registration system (NRMD) for clinical research, clinical trials, and post-marketing surveillance that JSRM currently operates, in response to the increasing needs for the registration of unrestricted medical care and advanced medical care. The registry service is available on the same platform as the registry system for clinical research, clinical trials, and post-marketing surveillance. An introductory website for REAP is currently under preparation. We will inform you when it is released. For inquiries about REAP, please contact us from the “CONTACT” page on this site.
The Japanese Society for Regenerative Medicine Database Committee aims to further develop and improve the NRMD based on user feedback. We welcome any inquiries or opinions - if you wish to use the database or have any questions, please contact us.